Author:
Hálfdánarson Óskar,Zoëga Helga,Aagaard Lise,Bernardo Miquel,Brandt Lena,Fusté Anna Coma,Furu Kari,Garuoliené Kristina,Hoffmann Falk,Huybrechts Krista F.,Kalverdijk Luuk J.,Kawakami Koji,Kieler Helle,Kinoshita Takuya,Litchfield Melisa,López Soffy C.,Machado-Alba Jorge E.,Machado-Duque Manuel E.,Mahesri Mufaddal,Nishtala Prasad S.,Pearson Sallie-Anne,Reutfors Johan,Saastamoinen Leena K.,Sato Izumi,Schuiling-Veninga Catharina C.M.,Shyu Yu-Chiau,Skurtveit Svetlana,Verdoux Hélène,Wang Liang-Jen,Yahni Corinne Zara,Bachmann Christian J.
Funder
The Chang Gung Memorial Hospital Research Project
Australian National Health and Medical Research Council
Centre of Research Excellence in Medicines and Ageing
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology
Reference60 articles.
1. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications;Abbing-Karahagopian;Eur. J. Clin. Pharmacol.,2014
2. Ahmad, O.B., Boschi-Pinto, C., Lopez, A.D., Murray, C.J., Lozano, R., Inoue, M., 2001. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series. World Health Organisation.
3. Increasing off-label use of antipsychotic medications in the United States, 1995–2008;Alexander;Pharmacoepidemiol. Drug Saf.,2011
4. Trends and patterns of antidepressant use in children and adolescents from five Western Countries, 2005–2012;Bachmann;Eur. Neuropsychopharmacol.,2016
5. Antipsychotic prescription in children and adolescents: an analysis of data from a German Statutory Health Insurance Company from 2005 to 2012;Bachmann;Dtsch. A¨rztebl. Int.,2014